In the recent presentation and Q&A Steve gave, Steve alluded to...

In the recent presentation and Q&A Steve gave, Steve alluded to the possibility of a "super-travelan" a product that fused the benefits of existing Travelan and CampETEC.
This announcement would suggest that the outcome of pending CampETEC trail being conducted by NMRC & John Hopkins is positive and this "super-travelan" concept has merit.
This also explains why the CampETEC (NCT06122870) trail has a Study Completion (Estimated) 2025-09 is a full 12 months after the Primary Completion (Estimated) 2024-09 all other trials the difference between Primary and Study is approx 3 months, as NMRC & John Hopkins must have intention of doing further studies on CampETEC for the purpose of what has now been announced.
All pieces of the puzzle coming together for IMC